News

A Breakthrough For Muscle-Invasive Bladder Cancer: Padcev Plus Keytruda Drug Combo Could Transform Treatment Around Surgery

Mar 2, 2026 in Bladder Cancer

'Potentially Practice-Changing': Targeted Therapy Improves Survival For Men With Subtype Of Advanced Prostate Cancer

Mar 2, 2026 in Prostate Cancer

FDA Approves New All-Oral Treatment Option For CLL: What This Means For Patients 

Feb 23, 2026 in Chronic Lymphocytic Leukemia (CLL)

A Simpler Monthly Option for EGFR-Targeted Treatment—What It Means for You

Feb 20, 2026

Bayer's Dr. Dominik Ruettinger On A Promising New Oral Treatment Option For Patients With HER2+ Lung Cancer

Feb 18, 2026

7 Years After Glioma Diagnosis, Vorasidenib Provides Lasting Control

Feb 18, 2026 in Glioma

The Pill Form Of GLP-1 Weight Loss Drugs Is Surging Among Urban, White Women According to Newly Released Data

Feb 18, 2026

Punk Rock Lou Koller From ‘Sick of It All’ Continues Fight With Esophageal Cancer Amid Treatment

Feb 18, 2026

The Strategy For Dramatic Impact on Breast Cancer Research: Support People Not Ideas, How Dr. Larry Norton and the BCRF Have Advanced Care For Millions of Women

Feb 12, 2026 in Breast Cancer

Beyond Shrinking Tumors — What Really Matters To Patients

Feb 12, 2026

A Survivor Helping Shape The Future Of Cancer Care

Feb 11, 2026

More Control, Better Quality Of Life: What To Know About Tarlatamab, The New Immunotherapy Approved For Small-Cell Lung Cancer

Feb 4, 2026 in Lung Cancer